Interview: John O’Hara – General Manager, Janssen Puerto Rico
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI’s HuProt protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.
The company’s microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.
CDI has patents in process for technologies to increase high through put analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers
At CDI we believe that partnering with both companies and academic scientists is the path to mutual success. So please contact our business development professionals for possible collaborations or partnerships.
The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.
Contact details
Guanajibo Research and Innovation Park
4005 Street B, Road 114 Km 1.3
Mayaguez, PR 00682
USA
T: 787-806-4010
F: 787-806-4006
www.cdi-lab.com
John O’Hara is the general manager and vice president of Janssen’s facilities in Puerto Rico as well as the head of the Janssen campus. He discusses the affiliate’s rapid growth…
José Pérez de Gracia, president of Farmacias Plaza, discusses the environment between multinational chains and local pharmacies as well as his own plan for extended growth throughout Puerto Rico in…
Prevention versus remediation is the name of the game in regulatory and compliance issues for pharmaceutical manufacturers; the cost of non-compliance is much higher than investing proactively in compliance. Elizabeth…
Daneris Fernández, CEO and president of DGF Consulting Group, outlines the firm’s services that help Latin American companies enter Puerto Rico as well as its focus on hospital consulting. What…
Miguel Centeno, general manager and head of Roche Diabetes Care in Puerto Rico, highlights the affiliate’s strong manufacturing performance in the area of diabetes care (DC) blood glucose test strips…
Ignacio Pino, president of CDI Laboratories Inc., discusses how his novel technology platform Hu-Prot will help pharmaceutical companies and academia develop drugs more efficiently through development of advanced antibodies. How…
The Puerto Rico Industrial Development Company (PRIDCO) is a government agency underneath the Puerto Rican Department of Economic Development and Commerce designed to facilitate industrial investments in the country from…
Frank Rodríguez, General Manager for Allergan Operations in Puerto Rico, discusses cost-competitiveness at his plants in Fajardo and Manatí, which manufacture hormones and solid dosage forms respectively. He also outlines…
Promoting the manufacturing industry of Puerto Rico is a key priority for Carlos Rivera, president of the Puerto Rico Manufacturers Association (PRMA). He discusses the strategies behind working with Washington…
Andrew Wirths arrived to Puerto Rico in 2013 to run Merck’s manufacturing operations on the island. He discusses how dynamic changes within the industry is impacting their competitive nature and…
Jaime García, executive director of the Puerto Rico Manufacturers Association, provides an overview of the current state of the industry in Puerto Rico today. You were named executive director of…
See our Cookie Privacy Policy Here
